CREDIT SUISSE AG/ - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 189 filers reported holding MYRIAD GENETICS INC in Q4 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$2,980,874
-25.5%
185,840
+7.6%
0.00%
-25.0%
Q2 2023$4,002,861
+15.7%
172,686
+15.9%
0.00%
+33.3%
Q1 2023$3,460,411
+31.8%
148,963
-17.7%
0.00%0.0%
Q4 2022$2,625,498
+9.4%
180,944
+43.9%
0.00%0.0%
Q3 2022$2,399,000
+5.7%
125,751
+0.7%
0.00%
+50.0%
Q2 2022$2,269,000
-35.7%
124,888
-10.8%
0.00%
-33.3%
Q1 2022$3,529,000
-27.7%
140,040
-20.8%
0.00%0.0%
Q4 2021$4,878,000
+13.5%
176,757
+32.8%
0.00%
+50.0%
Q3 2021$4,296,000
+11.8%
133,079
+5.9%
0.00%0.0%
Q2 2021$3,842,000
-6.4%
125,661
-6.8%
0.00%0.0%
Q1 2021$4,105,000
+8.9%
134,839
-29.2%
0.00%0.0%
Q4 2020$3,768,000
-9.8%
190,555
-40.5%
0.00%
-33.3%
Q3 2020$4,177,000
+45.7%
320,290
+26.7%
0.00%
+50.0%
Q2 2020$2,866,000
+72.3%
252,716
+117.6%
0.00%
+100.0%
Q1 2020$1,663,000
-51.9%
116,156
-8.5%
0.00%
-66.7%
Q4 2019$3,456,000
+91.8%
126,893
+101.6%
0.00%
+50.0%
Q3 2019$1,802,000
+8.0%
62,930
+4.8%
0.00%
+100.0%
Q2 2019$1,669,000
-11.0%
60,055
+6.3%
0.00%
-50.0%
Q1 2019$1,876,000
-74.3%
56,509
-77.5%
0.00%
-75.0%
Q4 2018$7,303,000
-14.2%
251,224
+35.7%
0.01%0.0%
Q3 2018$8,515,000
+235.2%
185,113
+172.5%
0.01%
+300.0%
Q2 2018$2,540,000
-62.0%
67,939
-69.9%
0.00%
-66.7%
Q1 2018$6,680,000
+49.2%
226,035
+73.5%
0.01%
+50.0%
Q4 2017$4,476,000
+3.0%
130,316
+8.4%
0.00%0.0%
Q3 2017$4,347,000
+0.1%
120,181
-28.4%
0.00%0.0%
Q2 2017$4,341,000
-0.6%
167,958
-26.1%
0.00%0.0%
Q1 2017$4,367,000
-9.7%
227,405
-21.6%
0.00%
-20.0%
Q4 2016$4,837,000
-23.9%
290,108
-6.1%
0.01%
-16.7%
Q3 2016$6,359,000
-44.7%
308,976
-17.8%
0.01%
-53.8%
Q2 2016$11,502,000
-1.8%
375,868
+20.1%
0.01%
-7.1%
Q1 2016$11,711,000
+21.4%
312,872
+39.9%
0.01%
+27.3%
Q4 2015$9,650,000
+8.8%
223,602
-5.5%
0.01%0.0%
Q3 2015$8,871,000
-22.0%
236,702
-29.3%
0.01%0.0%
Q2 2015$11,376,000
+6.7%
334,672
+11.1%
0.01%0.0%
Q1 2015$10,659,000
+41.9%
301,133
+36.6%
0.01%
+57.1%
Q4 2014$7,510,000
+32.1%
220,480
+49.6%
0.01%
+40.0%
Q3 2014$5,686,000
+36.2%
147,404
+37.4%
0.01%
+66.7%
Q2 2014$4,175,000
-2.7%
107,262
-14.6%
0.00%
-25.0%
Q1 2014$4,293,000
-67.0%
125,573
-79.8%
0.00%
-66.7%
Q4 2013$13,018,000
+125.0%
620,468
+152.0%
0.01%
+100.0%
Q3 2013$5,785,000
-33.8%
246,216
-24.3%
0.01%
-25.0%
Q2 2013$8,739,000
+54.6%
325,198
+46.2%
0.01%
+33.3%
Q1 2013$5,651,000222,4030.01%
Other shareholders
MYRIAD GENETICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders